29.12
-1.11
(-3.67%)
At close: April 16 at 4:00:01 PM EDT
29.21
+0.09
+(0.31%)
Pre-Market: 8:00:16 AM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| COWAN ELVIA Officer | Stock Award(Grant) | Feb 27, 2025 | 24,106 |
| DRAPEAU ANNE S Director | Stock Award(Grant) | Jun 6, 2024 | 7,175 |
| EYDELMAN MIKHAIL General Counsel | Sale | Mar 5, 2025 | 41,620 |
| GILBERT HALLEY E Director | Stock Award(Grant) | Jun 6, 2024 | 7,175 |
| GUGGENHIME ANDREW L President | Conversion of Exercise of derivative security | Apr 7, 2025 | 131,950 |
| LOXAM TERI Director | Sale | Jan 15, 2025 | 7,175 |
| LUKATCH HEATH SCOTT Director | Conversion of Exercise of derivative security | Apr 8, 2025 | 14,175 |
| PAYA CARLOS V Director | Stock Award(Grant) | Dec 6, 2024 | -- |
| PICKERING GRANT E Chief Executive Officer | Conversion of Exercise of derivative security | Apr 4, 2025 | 791,205 |
| WASSIL JAMES Chief Operating Officer | Sale | Mar 3, 2025 | 151,916 |
Related Tickers
ACLX Arcellx, Inc.
60.69
-1.20%
NAMS NewAmsterdam Pharma Company N.V.
16.03
-0.19%
RARE Ultragenyx Pharmaceutical Inc.
34.98
-1.02%
RVMD Revolution Medicines, Inc.
36.20
-0.33%
NUVL Nuvalent, Inc.
69.97
-1.14%
CYTK Cytokinetics, Incorporated
39.15
+1.53%
ZLAB Zai Lab Limited
28.94
-4.76%
EWTX Edgewise Therapeutics, Inc.
13.03
+0.08%
PTGX Protagonist Therapeutics, Inc.
45.80
-2.45%
INSM Insmed Incorporated
70.20
-1.22%